All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:
  1. Smiley

    Use of patient-reported outcome and experience measures in patient care and policy

    KCE Reports 303 (2018) Satisfaction questionnaires are increasingly used everywhere and hospitals are not immune to this trend.

    https://kce.fgov.be/en/use-of-patient-reported-outcome-and-experience-measures-in-patient-care-and-policy
  2. R288

    How to improve the Belgian process for Managed Entry Agreements? An analysis of the Belgian and international experience

    KCE Reports 288 (2017)

    https://kce.fgov.be/en/how-to-improve-the-belgian-process-for-managed-entry-agreements-an-analysis-of-the-belgian-and
  3. R283

    Horizon scanning for pharmaceuticals: proposal for the BeNeLuxA collaboration

    KCE Reports 283 (2017)

    https://kce.fgov.be/en/horizon-scanning-for-pharmaceuticals-proposal-for-the-beneluxa-collaboration

  4. Multi-criteria decision analysis for the appraisal of medical needs: a pilot study

    KCE Reports 272 (2016) Templates docx fileTOOL FOR ASSESSING AND REPORTING THE QUALITY OF EVIDENCE (61 KB) docx fileHTAI - TEMPLATE WRITTEN CONSULTATION PATIENT GROUPS NON MEDICINES HTA (55 KB) docx fileHTAI - TEMPLATE WRITTEN CONSULTATION PATIENT GROUPS MEDICINES HTA (53 KB) xlsx fileMCDA TOOL FOR CREATING A RANK ORDER OF NEEDS (31 KB) docx fileSUBMISSION TEMPLATE FOR THE UNMET MEDICAL NEEDS LIST (55 KB)

    https://kce.fgov.be/en/multi-criteria-decision-analysis-for-the-appraisal-of-medical-needs-a-pilot-study

  5. Future scenarios about drug development and drug pricing

    KCE Reports 271 (2016)

    https://kce.fgov.be/en/future-scenarios-about-drug-development-and-drug-pricing

  6. Towards a better managed off-label use of drugs

    KCE Reports 252 (2015)

    https://kce.fgov.be/en/towards-a-better-managed-off-label-use-of-drugs

  7. Incorporating societal preferences in reimbursement decisions – Relative importance of decision criteria according to Belgian citizens

    KCE Reports 234 (2014)

    https://kce.fgov.be/en/incorporating-societal-preferences-in-reimbursement-decisions-%E2%80%93-relative-importance-of-decision

  8. Models for citizen and patient involvement in health care policy Part I: Exploration of their feasibility and acceptability

    KCE Reports 195 (2013)

    https://kce.fgov.be/en/models-for-citizen-and-patient-involvement-in-health-care-policy-part-i-exploration-of-their
  9. R186

    [Principles and criteria for the level of patient cost sharing: Reflections on value-based insurance]

    KCE Reports 186 (2012)

    https://kce.fgov.be/en/principles-and-criteria-for-the-level-of-patient-cost-sharing-reflections-on-value-based-insurance

  10. Simplification of patient cost sharing: the example of physician consultations and visits

    KCE Reports 180 (2012)

    https://kce.fgov.be/en/simplification-of-patient-cost-sharing-the-example-of-physician-consultations-and-visits

  11. Drug reimbursement systems: international comparison and policy recommendations

    KCE Reports 147 (2010)

    https://kce.fgov.be/en/drug-reimbursement-systems-international-comparison-and-policy-recommendations

  12. [Radioisotopes Reimbursement in Belgium]

    KCE Reports 79 (2008)

    https://kce.fgov.be/en/radioisotopes-reimbursement-in-belgium

  13. [Organisation and financing of musculoskeletal and neurological rehabilitation in Belgium]

    KCE Reports 57 (2007)

    https://kce.fgov.be/en/organisation-and-financing-of-musculoskeletal-and-neurological-rehabilitation-in-belgium

  14. [An evaluation procedure for the emerging medical technologies]

    KCE Reports 44 (2006)

    https://kce.fgov.be/en/an-evaluation-procedure-for-the-emerging-medical-technologies